Discover
Innovation
Investment
Excellence
EVENTS
View all
NEWSROOM
View all
EuropaBio position paper for the proposal on establishing a framework of measures for strengthening Europe’s net-zero technology products manufacturing ecosystem (Net-Zero Industry Act)
“EuropaBio is pleased to see this first step in the modernisation of the GM framework and calls for an extension into micro-organisms”
Reform of the EU General Pharmaceutical Legislation Joint Position Paper on the Hospital Exemption Scheme for ATMPs
In the context of the revision of the EU General Pharmaceutical Legislation, this paper puts forward joint recommendations from ARM (Alliance for Regenerative Medicine), EFPIA (European Federation of Pharmaceutical Industries and Associations), EuropaBio, EUCOPE (European Confederation of Pharmaceutical Entrepreneurs) and ISCT (International Society for Cell & Gene Therapy), for the reform of the Hospital Exemption (HE) scheme for Advanced Therapy Medicinal Products (ATMPs).
The NGT proposal is an important step towards Europe’s bioeconomy-driven strategic autonomy, competitiveness and sustainability ambitions
“EuropaBio is pleased to see this first step in the modernisation of the GM framework and calls for an extension into micro-organisms”